39 results on '"PERUNICIC, JOVAN"'
Search Results
2. Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application
3. Echocardiographic study of early left ventricular remodeling in highly trained preadolescent footballers
4. Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial
5. Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome
6. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction
7. Rationale and Design of the On-Treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) Randomized Trial
8. Significance of recurrences of new atrial fibrillation in acute myocardial infarction
9. Impact of the Combined Left Ventricular Systolic and Renal Dysfunction on One-Year Outcomes after Primary Percutaneous Coronary Intervention
10. Development and Validation of a Risk Scoring Model to Predict Net Adverse Cardiovascular Outcomes after Primary Percutaneous Coronary Intervention in Patients Pretreated with 600 mg Clopidogrel: Rationale and Design of the RISK-PCI Study
11. Transient Left Ventricular Apical Ballooning Complicated by a Mural Thrombus and Outflow Tract Obstruction in a Patient with Pheochromocytoma
12. Salvage Late Plasmapheresis in a Patient With Pulmonary Embolism Caused by Heparin-Induced Thrombocytopenia Primarily Resistant to Danaparoid Sodium and Lepirudin
13. Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II
14. Modern clinical retrospective on ventricular rhythm disturbances in acute myocardial infarction: Latest treatment mode according to the valid recommendations
15. PM206 Beck’s depression inventory score correlation with clinical, biochemical and haemostatic parameters in postmyocardial infarction patients
16. PM099 Clinical presentation and prognosis of patients with acute aortic intramural hematoma
17. Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register
18. Sex-Related Analysis of Short- and Long-term Clinical Outcomes and Bleeding Among Patients Treated With Primary Percutaneous Coronary Intervention: An Evaluation of the RISK-PCI Data
19. Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial
20. Predictors of In-Hospital Mortality in Patients with Acute Inferior Infarction of the Left Ventricle Accompanied by Right Ventricular Infarction when Treated with Percutaneous Coronary Intervention
21. Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score
22. Simple Risk Algorithm to Predict Serious Bleeding in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
23. Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial
24. Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention
25. Impact of the Combined Left Ventricular Systolic and Renal Dysfunction on One‐Year Outcomes after Primary Percutaneous Coronary Intervention
26. Right Ventricular Takotsubo Cardiomyopathy
27. Obstacles in the diagnostics and therapy of heparin-induced thrombocytopenia
28. Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome
29. Temporal Variations at the Onset of Spontaneous Acute Aortic Dissection
30. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction
31. High-dose streptokinase in the treatment of acute massive pulmonary embolism complicated with cardiogenic shock, respiratory arrest and ventricular fibrillation
32. Heparin induced thrombocytopenia type ii and myocardial infarction: Two case reports
33. Prognosis of women compared with men with heart failure and acute myocardial infarction after previous revascularization
34. Development and Validation of a Risk Scoring Model to Predict Net Adverse Cardiovascular Outcomes after Primary Percutaneous Coronary Intervention in Patients Pretreated with 600 mg Clopidogrel: Rationale and Design of the RISK-PCI Study.
35. Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia.
36. Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register
37. Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.
38. Prognostic significance of the occurrence of acute heart failure after successful primary percutaneous coronary intervention.
39. The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.